NCT03793491 (PSYCHO-PERF) is a clinical trial of TCI scale in Parkinson Disease, sponsored by University Hospital, Toulouse.

Who is sponsoring NCT03793491?

NCT03793491 is sponsored by University Hospital, Toulouse.

What drugs are being tested in NCT03793491?

Interventions in NCT03793491: TCI scale, PDQ-39 scale.

What condition does NCT03793491 study?

NCT03793491 studies Parkinson Disease.

Is NCT03793491 still recruiting?

NCT03793491 is currently status unknown. Last updated 4 January 2019.

Last reviewed 2019-01-04 · How we verify

NCT03793491: PSYCHO-PERF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson's Disease

Status unknown Last updated 4 January 2019

What this trial tests

trial testing TCI scale in Parkinson Disease in 60 participants. Status unknown.

Timeline

18 December 2018

Primary endpoint
18 December 2020

18 June 2021

Quick facts

Lead sponsor	University Hospital, Toulouse
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	60
Start date	18 December 2018
Primary completion	18 December 2020
Estimated completion	18 June 2021
Sites	1 location across France

Drugs / interventions tested

TCI scale
PDQ-39 scale

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

University Hospital, Toulouse

Who can join

18 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate if patients' personality could be considerate as predictive factor of quality of life after the establishment of continuous infusion of dopaminergic treatments to observe if there are predictive personality's profiles of specific therapeutic response (Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) or continuous infusion).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Personality and quality-of-life improvement after apomorphine infusion in Parkinson's disease.
Boussac M, Harroch E, Barthelemy C, Ory-Magne F, et al · · 2024 · cited 1× · PMID 38846534 · DOI 10.1093/braincomms/fcae181

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other University Hospital, Toulouse trials

Trials by the same sponsor.

NCT07497750 — Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver D · NA · not yet recruiting
NCT07507240 — The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Tre · NA · not yet recruiting
NCT07524088 — Contamination of Young Children Hair During Acute Cannabis Intoxication · NA · not yet recruiting
NCT07470580 — Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension · NA · not yet recruiting
NCT07423988 — Evaluation of Changes in Sleep Efficiency Among PIC DU MIDI Staff Between Nights Spent at Home and Nights Spent in the W · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03793491 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Toulouse
Last refreshed: 4 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03793491.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing